Prognoza

Nie mamy danych analityków dla tej spółki.

Wiadomości Przejdź do aktualności

Biotalys receives EPA approval for bio-fungicide Evoca and shares rise

The US Environmental Protection Agency (EPA) has approved Biotalys's first bio-fungicide, Evoca, completing the regulatory review process. After the approval, Biotalys can submit registration applications in California and Florida, the main US growing regions for fruits and vegetables. Evoca targets fungal diseases such as Botrytis and powdery mildew; the company is also developing a more efficiently manufactured successor version (Evoca NG) with expected US approval in 2028/2029 and EU/Brazil approval in 2029/2030. » Więcej na de.investing.com
Biotalys shares rise after positive EPA vote for Evoca

Biotalys shares gained about 14% after the US Environmental Protection Agency (EPA) issued a proposed approval for the protein-based biofungicide Evoca. The EPA is thus initiating the final phase of the review process; stakeholders can comment within 15 days before the final decision is made. Evoca is seen as an important test for Biotalys’ business model; the company has production and distribution agreements with Novonesis and AgroFresh. Analysts at Kepler view the vote as a clear breakthrough for the investment case, also ahead of a possible EU approval. » Więcej na de.investing.com

Dane finansowe spółki

W ostatnim kwartale Biotalys NV Actions au Porteur o.N. osiągnęła przychody w wysokości 0 € i zysk netto w wysokości -4,57 mln €

(EUR)	czerwiec 2026	YoY
Przychody	0	100,00%
Zysk brutto	0	100,00%
Zysk netto	-4,57 mln	12,39%
EBITDA	-3,33 mln	8,33%

Dane fundamentalne

Wskaźnik	Wartość
Kapitalizacja rynkowa	89,98 mln €
Liczba akcji	45,44 mln
Maksimum/minimum z 52 tygodni	5,28 € - 1,56 €
Dywidendy	Nie
Beta	1,37
C/Z (PE Ratio)	-4,50
PEG (PEG Ratio)	0,64
C/WK (PB Ratio)	5,20
C/S (PS Ratio)	0,00

Profil spółki

Biotalys NV, ein Agrartechnologieunternehmen, erforscht und entwickelt neuartige biologische Produkte für den Schutz von Lebensmitteln und Nutzpflanzen. Das Unternehmen entwickelt hauptsächlich Biofungizide, Bioinsektizide und Biobakterizide. Das Unternehmen war früher unter dem Namen Agrosavfe NV bekannt. Biotalys NV wurde im Jahr 2013 gegründet und hat seinen Hauptsitz in Gent, Belgien.